Real-world Bicohort Observational Study of a Pertuzumab Biosimilar in the Treatment of Breast Cancer: in the Neoadjuvant Setting and in First-line Metastatic Disease
This is not medical advice. AI-assisted translation — inaccuracies may occur. Always verify the original and consult your oncologist before taking any steps.
About the trial
The goal of this observational study is to describe the real-world utilization patterns of a pertuzumab biosimilar and to evaluate its clinical outcomes in patients with breast cancer in both neoadjuvant and metastatic settings. It also aims to assess pathological complete response (pCR), disease-free survival (DFS) in the neoadjuvant cohort, progression-free survival (PFS) in the metastatic cohort, overall survival (OS), treatment response, and safety and tolerability (adverse events according to CTCAE) across both cohorts.
Original English text from ClinicalTrials.gov
Who can (and can't) join
✓ Qualifies
- •Pacjenci w wieku 19 lat lub starsi.
- •Potwierdzony rak piersi (zaznaczony jako HER2-pozytywny).
- •Pacjenci, u których zdecydowano o leczeniu lekiem podobnym do pertuzumabu.
- •Leczenie jest częścią standardowej opieki medycznej, a nie badania klinicznego.
- •Pacjent wyraził zgodę na udział.
✗ Disqualifies
- •Leczenie lekiem podobnym do pertuzumabu w innym przypadku niż przed operacją lub pierwsza linia leczenia zaawansowanego raka.
- •Pacjenci biorący udział w innym badaniu klinicznym.
- •Znana ciężka alergia lub przeciwwskazanie do stosowania pertuzumabu.
- •Brak możliwości śledzenia stanu pacjenta przez co najmniej 6 miesięcy.
Simplified criteria — AI translation
Trial details
- Minimum age
- 19 Years
- Last updated (source)
- April 21, 2026
- Sex
- Female only
Locations (2)
CAC BLIDA, Algiers, Algeria 16000
Algiers, Algeria
CHU Béni Messous, Algiers, Algeria 16000
Algiers, Algeria
Trial contact
BOUNEDJAR Adda, Professor
Oukkal Mohammed, Professor
Contact information from ClinicalTrials.gov. Contact in English.
Share this trial
Data from ClinicalTrials.gov. AI-assisted translation, last sync: 7/1/2026.
You can help another person
We fund the Radar, this site, and the development of our Grosz dla Życia fundraising platform from donations and our own resources. Every contribution, even a small one, really helps.